Takeda, Masayuki
Kindai University
2 papers on CoChatORCID 0000-0002-2950-0960
Most cited papers
- Verified
Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non–Small-Cell Lung Cancer
Haratani, K., Hayashi, H., Chiba, Y., Kudo, K., Yonesaka, K., Kato, R., Kaneda, H., Hasegawa, Y., Tanaka, K., Takeda, M., et al. (2018) · JAMA Oncology
Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations
Cited by 1,003
- Verified
Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab
Yonesaka, K., Zejnullahu, K., Okamoto, I., Satoh, T., Cappuzzo, F., Souglakos, J., Ercan, D., Rogers, A., Roncalli, M., Takeda, M., et al. (2011) · Science Translational Medicine
HER2/EGFR in Cancer ResearchColorectal Cancer Treatments and Studies
Cited by 663
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free